Daito PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Daito PharmaceuticalLtd has a total shareholder equity of ¥52.0B and total debt of ¥7.3B, which brings its debt-to-equity ratio to 14%. Its total assets and total liabilities are ¥77.4B and ¥25.3B respectively. Daito PharmaceuticalLtd's EBIT is ¥4.2B making its interest coverage ratio -110.8. It has cash and short-term investments of ¥3.8B.
Key information
14.0%
Debt to equity ratio
JP¥7.30b
Debt
Interest coverage ratio | -110.8x |
Cash | JP¥3.79b |
Equity | JP¥52.04b |
Total liabilities | JP¥25.31b |
Total assets | JP¥77.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4577's short term assets (¥42.9B) exceed its short term liabilities (¥18.7B).
Long Term Liabilities: 4577's short term assets (¥42.9B) exceed its long term liabilities (¥6.6B).
Debt to Equity History and Analysis
Debt Level: 4577's net debt to equity ratio (6.8%) is considered satisfactory.
Reducing Debt: 4577's debt to equity ratio has reduced from 24.2% to 14% over the past 5 years.
Debt Coverage: 4577's debt is well covered by operating cash flow (67.9%).
Interest Coverage: 4577 earns more interest than it pays, so coverage of interest payments is not a concern.